nn nn
PART nnONE: nnESSENTIAL nnCONCEPTS nnFOR nnTHE nnPRESCRIPTION nnOF nnMEDICATIONS
Unit nn1: nnFoundations nnof nnPrescriptive nnPractice
1. Prescriptive nnAuthority nnand nnRole nnImplementation: nnTradition nnvs. nnChange
2. Historical nnReview nnof nnPrescriptive nnAuthority: nnThe nnRole nnof nnNurses nn(NPs, nnCNMs, nnCRNAs, nnand
nnCNSs) nnand nnPhysician nnAssistants
Unit nn2: nnPharmacokinetics nnand nnPharmacodynamics
3. General nnPharmacokinetic nnand nnPharmacodynamic nnPrinciples
4. Special nnPopulations: nnGeriatrics
5. Special nnPopulations: nnPediatrics
6. Special nnPopulations: nnPregnant nnand nnNursing nnWomen
7. Over-the-Counter n n Medications
8. Complementary nnand nnAlternative nnTherapies
Unit nn3: nnThe nnArt nnand nnScience nnof nnPharmacotherapeutics
9. Establishing nnthe nnTherapeutic nnRelationship
10. Practical nnTips nnon nnWriting nnPrescriptions
11. Evidence-Based nnDecision-Making nnand nnTreatment nnGuidelines
12. Design nnand nnImplementation nnof nnPatient nnEducation
PART nnTWO: nnDRUG nnMONOGRAPHS
Unit nn4: nnTopical nnAgents
13. Dermatologic nn Agents
14. Eye, nnEar, nnThroat, nnand nnMouth nnAgents
Unit nn5: nnRespiratory nnAgents
15. Upper nnRespiratory nnAgents
16. Asthma nnand nnChronic nnObstructive nnPulmonary nnDisease nnMedications
Unit nn6: nnCardiovascular nnAgents
17. Hypertension nnand nnMiscellaneous nnAntihypertensive nnMedications
18. Coronary nnArtery nnDisease nnand nnAntianginal nnMedications
19. Heart nnFailure nnand nnDigoxin
20. β-Blockers
21. Calcium nnChannel nnBlockers
,22. ACE nnInhibitors nnand nnAngiotensin nnReceptor nnBlockers
23. Antiarrhythmic n n Agents
24. Antihyperlipidemic n n Agents
25. Agents nnthat nnAct nnon nnBlood
Unit nn7: nnGastrointestinal nnAgents
26. Antacids nnand nnthe nnManagement nnof nnGERD
27. Histamine-2 nnBlockers nnand nnProton nnPump nnInhibitors
28. Laxatives
29. Antidiarrheals
30. Antiemetics
31. Medications nnfor nnIrritable nnBowel nnSyndrome nnand nnOther nnGastrointestinal nnProblems
Unit nn8: nnRenal/Genitourinary nnAgents
32. Diuretics
33. Male nnGenitourinary nnAgents
34. Drugs nnfor nnUrinary nnIncontinence nnand nnUrinary nnAnalgesia
Unit nn9: nnMusculoskeletal nnAgents
35. Acetaminophen
36. Aspirin nnand nnNonsteroidal nnAntiinflammatory nnDrugs
37. Disease-Modifying nnAntirheumatic nnDrugs nnand nnImmune nnModulators
38. Gout nnMedications
39. Osteoporosis nn Treatment
40. Muscle nnRelaxants
Unit nn10: nnCentral nnNervous nnSystem nnAgents
41. Medications nnfor nnAttention nnDeficit nnHyperactivity nnDisorder
42. Medications nnfor nnDementia
43. Analgesia nnand nnPain nnManagement
44. Migraine nnMedications
45. Antiepileptics
46. Antiparkinson n n Agents
Unit nn11: nnPsychotropic nnAgents
, 47. Antidepressants
48. Antianxiety nnand nnAntiinsomnia nnAgents
49. Antipsychotics
50. Substance nnAbuse
Unit nn12: nnEndocrine nnAgents
52. nn Glucocorticoids
52. Thyroid nnMedications
53. Diabetes nnMellitus nnAgents
Unit nn13: nnReproductive nnSystem nnMedications
54. Contraceptives
55. Hormone nnReplacement nnTherapy nn– nnNEW nnTitle/Focus!
56. Drugs nnfor nnBreast nnCancer
Unit nn14: nnAntiinfectives
57. Principles nnfor nnPrescribing nnAntiinfectives
58. Treatment nnof nnSpecific nnInfections nnand nnMiscellaneous nnAntibiotics
59. Penicillins
60. Cephalosporins
61. Tetracyclines
62. Macrolides
63. Fluoroquinolones
64. Aminoglycosides
65. Sulfonamides
66. Antitubercular n n Agents
67. Antifungals
68. Antiretroviral n n Medications
69. Antiviral nnand nnAntiprotozoal nnAgents
Unit nn15: nnHealth nnPromotion
70. Immunizations nnand nnBiologicals
71. Weight nnManagement
72. Smoking nnCessation